This Is CDR Ep. 78: Equatic Updates with Dr. Lorenzo Corsini.

This week we welcome Equatic Principal Advisor Dr. Lorenzo Corsini to This Is CDR to update us on the company's evolution and progress since SeaChange was on the program in December 2021, and discuss the electrochemical mCDR company's recent offtake purchase agreement with Boeing, the road ahead, and path to scale. About Lorenzo: Dr. Lorenzo Corsini is an entrepreneur and scientist. Prior to joining Equatic, he co-founded and built PhagoMed, a biotech startup developing precision antimicrobials, which was exited to BioNTech in 2021. Before that, he spent nine years at BCG in roles of increasing seniority. Lorenzo has degrees in biochemistry and business administration and a Ph.D. in molecular biology All the links you need to get to know and follow today’s guest Equatic! https://www.equatic.tech/ https://twitter.com/equatic_tech UCLA ICM https://icm.ucla.edu/ https://www.linkedin.com/in/lorenzo-corsini/ Jobs at Equatic - https://www.equatic.tech/careers And Equatic (formerly SEA CHANGE) on TICDR Ep10 (Dec 2021) w/ SEA CHANGE https://www.youtube.com/watch?v=9XJ4A9yjeS8 https://www.equatic.tech/articles/equatic-launches-low-cost-gigaton-scale-technology-to-decarbonize-at-unprecedented-speed https://www.bloomberg.com/news/articles/2023-05-12/new-carbon-dioxide-removal-project-relies-on-ocean-to-reach-net-zero Paper on the science behind Equatic’s process https://www.equatic.tech/publications/electrolytic-seawater-mineralization-and-how-it-ensures-net-carbon-dioxide-removal.